financetom
Business
financetom
/
Business
/
Market Chatter: Meta Platforms Mulling Paid Version of AI Chatbot
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Meta Platforms Mulling Paid Version of AI Chatbot
May 24, 2024 4:42 AM

07:24 AM EDT, 05/24/2024 (MT Newswires) -- Meta Platforms ( META ) is mulling a paid version of its artificial intelligence-backed assistant Meta AI, The Information reported Thursday, citing an internal post.

The move mirrors offerings from Microsoft (MSFT) and Alphabet's (GOOG, GOOGL), both of which charge fees that give users priority access to their chatbots and allow for their use in workplace applications, the report added.

The Information said the features and prices of Meta's paid AI assistant could not be learned and that the company's plan could still change.

Meta Platforms ( META ) did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 467.60, Change: +1.82, Percent Change: +0.39

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fulcrum Therapeutics Suspends Rare Muscular Disease Candidate After Disappointing Data From Pivotal Trial
Fulcrum Therapeutics Suspends Rare Muscular Disease Candidate After Disappointing Data From Pivotal Trial
Sep 13, 2024
Fulcrum Therapeutics Inc ( FULC ). stock is trading lower on Thursday after the company released data from the Phase 3 REACH trial evaluating losmapimod in patients with Facioscapulohumeral Muscular Dystrophy (FSHD). The study did not achieve its primary endpoint of change from baseline in relative surface area (RSA) with losmapimod compared to placebo. Also Read: Fulcrum Therapeutics Upgraded: BofA Debates Pivotal...
GM in talks to buy Chinese EV batteries built in the US, Bloomberg News reports
GM in talks to buy Chinese EV batteries built in the US, Bloomberg News reports
Sep 13, 2024
(Reuters) - General Motors ( GM ) is in talks to buy electric vehicle batteries relying on technology from China's CATL, assembled at a new plant to be built in the US, Bloomberg News reported on Thursday, citing people familiar with the matter. The factory would be funded and operated by Japanese consumer electronic firm TDK Corp ( TTDKF ),...
Maximus Secures $40 Million Task Order From Internal Revenue Service
Maximus Secures $40 Million Task Order From Internal Revenue Service
Sep 13, 2024
11:35 AM EDT, 09/12/2024 (MT Newswires) -- Maximus ( MMS ) said Thursday it was awarded a $40 million five-year task order by the Internal Revenue Service for the development and modernization of the IRS Enterprise Data Platform. Under this new task order, Maximus ( MMS ) will assist the IRS with analysis, planning, and operationalization as well as help...
What's Going On With AST SpaceMobile Stock?
What's Going On With AST SpaceMobile Stock?
Sep 13, 2024
AST SpaceMobile, Inc. ( ASTS ) shares are moving lower on heavy volume Thursday. The company announced the successful launch of its first five commercial satellites today. The Details: AST SpaceMobile ( ASTS ) launched the Bluebird satellites at 4:52 a.m. ET from Cape Canaveral, Florida. The large arrays of antennas are designed to reach standard smartphones directly at cellular...
Copyright 2023-2026 - www.financetom.com All Rights Reserved